198 related articles for article (PubMed ID: 34434164)
1. Frequency of Heterozygous Parkin (
Castelo Rueda MP; Raftopoulou A; Gögele M; Borsche M; Emmert D; Fuchsberger C; Hantikainen EM; Vukovic V; Klein C; Pramstaller PP; Pichler I; Hicks AA
Front Neurol; 2021; 12():706145. PubMed ID: 34434164
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous PRKN mutations are common but do not increase the risk of Parkinson's disease.
Zhu W; Huang X; Yoon E; Bandres-Ciga S; Blauwendraat C; Billingsley KJ; Cade JH; Wu BP; Williams VH; Schindler AB; Brooks J; Gibbs JR; Hernandez DG; Ehrlich D; Singleton AB; Narendra DP
Brain; 2022 Jun; 145(6):2077-2091. PubMed ID: 35640906
[TBL] [Abstract][Full Text] [Related]
3. Assessing the relationship between monoallelic PRKN mutations and Parkinson's risk.
Lubbe SJ; Bustos BI; Hu J; Krainc D; Joseph T; Hehir J; Tan M; Zhang W; Escott-Price V; Williams NM; Blauwendraat C; Singleton AB; Morris HR;
Hum Mol Genet; 2021 Mar; 30(1):78-86. PubMed ID: 33448283
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of induced pluripotent stem cell (iPSC) lines of two asymptomatic individuals carrying a heterozygous exon 7 deletion in Parkin (PRKN) and two non-carriers from the same family.
Castelo Rueda MP; Gilmozzi V; Riekschnitz DA; Di Segni M; Silipigni R; Pramstaller PP; Hicks AA; Pichler I; Zanon A
Stem Cell Res; 2022 Apr; 60():102692. PubMed ID: 35121197
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study.
Tan MMX; Malek N; Lawton MA; Hubbard L; Pittman AM; Joseph T; Hehir J; Swallow DMA; Grosset KA; Marrinan SL; Bajaj N; Barker RA; Burn DJ; Bresner C; Foltynie T; Hardy J; Wood N; Ben-Shlomo Y; Grosset DG; Williams NM; Morris HR
Brain; 2019 Sep; 142(9):2828-2844. PubMed ID: 31324919
[TBL] [Abstract][Full Text] [Related]
6. Long-Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson's Disease.
Daida K; Funayama M; Billingsley KJ; Malik L; Miano-Burkhardt A; Leonard HL; Makarious MB; Iwaki H; Ding J; Gibbs JR; Ishiguro M; Yoshino H; Ogaki K; Oyama G; Nishioka K; Nonaka R; Akamatsu W; Blauwendraat C; Hattori N
Mov Disord; 2023 Dec; 38(12):2249-2257. PubMed ID: 37926948
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Heterozygous PRKN Variants and Copy-Number Variations in Parkinson's Disease.
Yu E; Rudakou U; Krohn L; Mufti K; Ruskey JA; Asayesh F; Estiar MA; Spiegelman D; Surface M; Fahn S; Waters CH; Greenbaum L; Espay AJ; Dauvilliers Y; Dupré N; Rouleau GA; Hassin-Baer S; Fon EA; Alcalay RN; Gan-Or Z
Mov Disord; 2021 Jan; 36(1):178-187. PubMed ID: 32970363
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism.
Borsche M; König IR; Delcambre S; Petrucci S; Balck A; Brüggemann N; Zimprich A; Wasner K; Pereira SL; Avenali M; Deuschle C; Badanjak K; Ghelfi J; Gasser T; Kasten M; Rosenstiel P; Lohmann K; Brockmann K; Valente EM; Youle RJ; Grünewald A; Klein C
Brain; 2020 Oct; 143(10):3041-3051. PubMed ID: 33029617
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson's disease.
Trinh J; Hicks AA; König IR; Delcambre S; Lüth T; Schaake S; Wasner K; Ghelfi J; Borsche M; Vilariño-Güell C; Hentati F; Germer EL; Bauer P; Takanashi M; Kostić V; Lang AE; Brüggemann N; Pramstaller PP; Pichler I; Rajput A; Hattori N; Farrer MJ; Lohmann K; Weissensteiner H; May P; Klein C; Grünewald A
Brain; 2023 Jul; 146(7):2753-2765. PubMed ID: 36478228
[TBL] [Abstract][Full Text] [Related]
10. Task matters - challenging the motor system allows distinguishing unaffected Parkin mutation carriers from mutation-free controls.
Prasuhn J; Borsche M; Hicks AA; Gögele M; Egger C; Kritzinger C; Pichler I; Castelo-Rueda MP; Langlott L; Kasten M; Mascalzoni D; Klein C; Pramstaller PP; Brüggemann N
Parkinsonism Relat Disord; 2021 May; 86():101-104. PubMed ID: 33895538
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations.
Deng H; Le WD; Hunter CB; Ondo WG; Guo Y; Xie WJ; Jankovic J
Arch Neurol; 2006 Feb; 63(2):273-7. PubMed ID: 16476817
[TBL] [Abstract][Full Text] [Related]
12. Rare and novel variants of PRKN and PINK1 genes in Vietnamese patients with early-onset Parkinson's disease.
Ton ND; Thuan ND; Thuong MTH; Ngoc TTB; Nhung VP; Hoa NTT; Nam NH; Dung HT; Son ND; Ba NV; Bac ND; Tai TN; Dung LTK; Hung NT; Duong NT; Ha NH; Hai NV
Mol Genet Genomic Med; 2020 Oct; 8(10):e1463. PubMed ID: 32856414
[TBL] [Abstract][Full Text] [Related]
13. Parkin mRNA Expression Levels in Peripheral Blood Mononuclear Cells in Parkin-Related Parkinson's Disease.
Papagiannakis N; Liu H; Koros C; Simitsi AM; Stamelou M; Maniati M; Buena-Atienza E; Kartanou C; Karadima G; Makrythanasis P; Vatsellas G; Valente EM; Gasser T; Stefanis L
Mov Disord; 2024 Apr; 39(4):715-722. PubMed ID: 38357851
[TBL] [Abstract][Full Text] [Related]
14. Parkin mutations and early-onset parkinsonism in a Taiwanese cohort.
Wu RM; Bounds R; Lincoln S; Hulihan M; Lin CH; Hwu WL; Chen J; Gwinn-Hardy K; Farrer M
Arch Neurol; 2005 Jan; 62(1):82-7. PubMed ID: 15642853
[TBL] [Abstract][Full Text] [Related]
15. Molecular phenotypes of mitochondrial dysfunction in clinically non-manifesting heterozygous PRKN variant carriers.
Castelo Rueda MP; Zanon A; Gilmozzi V; Lavdas AA; Raftopoulou A; Delcambre S; Del Greco M F; Klein C; Grünewald A; Pramstaller PP; Hicks AA; Pichler I
NPJ Parkinsons Dis; 2023 Apr; 9(1):65. PubMed ID: 37072441
[TBL] [Abstract][Full Text] [Related]
16. Olfaction in Parkin single and compound heterozygotes in a cohort of young onset Parkinson's disease patients.
Malek N; Swallow DM; Grosset KA; Lawton MA; Smith CR; Bajaj NP; Barker RA; Ben-Shlomo Y; Bresner C; Burn DJ; Foltynie T; Morris HR; Williams N; Wood NW; Grosset DG;
Acta Neurol Scand; 2016 Oct; 134(4):271-6. PubMed ID: 26626018
[TBL] [Abstract][Full Text] [Related]
17. Analysis of PRKN Variants and Clinical Features in Polish Patients with Parkinson's Disease.
Oczkowska A; Florczak-Wyspianska J; Permoda-Osip A; Owecki M; Lianeri M; Kozubski W; Dorszewska J
Curr Genomics; 2015 Aug; 16(4):215-23. PubMed ID: 27006626
[TBL] [Abstract][Full Text] [Related]
18. Genotype-phenotype correlation in PRKN-associated Parkinson's disease.
Menon PJ; Sambin S; Criniere-Boizet B; Courtin T; Tesson C; Casse F; Ferrien M; Mariani LL; Carvalho S; Lejeune FX; Rebbah S; Martet G; Houot M; Lanore A; Mangone G; Roze E; Vidailhet M; Aasly J; Gan Or Z; Yu E; Dauvilliers Y; Zimprich A; Tomantschger V; Pirker W; Álvarez I; Pastor P; Di Fonzo A; Bhatia KP; Magrinelli F; Houlden H; Real R; Quattrone A; Limousin P; Korlipara P; Foltynie T; Grosset D; Williams N; Narendra D; Lin HP; Jovanovic C; Svetel M; Lynch T; Gallagher A; Vandenberghe W; Gasser T; Brockmann K; Morris HR; Borsche M; Klein C; Corti O; Brice A; Lesage S; Corvol JC;
NPJ Parkinsons Dis; 2024 Mar; 10(1):72. PubMed ID: 38553467
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations.
González-Casacuberta I; Morén C; Juárez-Flores DL; Esteve-Codina A; Sierra C; Catalán-García M; Guitart-Mampel M; Tobías E; Milisenda JC; Pont-Sunyer C; Martí MJ; Cardellach F; Tolosa E; Artuch R; Ezquerra M; Fernández-Santiago R; Garrabou G
Neurobiol Aging; 2018 May; 65():206-216. PubMed ID: 29501959
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy, fertile life factors, and associated clinical course in PRKN early-onset Parkinson's disease.
Bovenzi R; Conti M; Degoli GR; Cerroni R; Artusi CA; Pierantozzi M; Stefani A; Mercuri NB; Schirinzi T
Neurol Sci; 2024 Feb; 45(2):591-599. PubMed ID: 37658959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
